United States v. William Mikaitis

33 F.4th 393
CourtCourt of Appeals for the Seventh Circuit
DecidedApril 29, 2022
Docket20-2783
StatusPublished
Cited by1 cases

This text of 33 F.4th 393 (United States v. William Mikaitis) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. William Mikaitis, 33 F.4th 393 (7th Cir. 2022).

Opinion

In the

United States Court of Appeals For the Seventh Circuit ____________________ No. 20‐2783 UNITED STATES OF AMERICA, Plaintiff‐Appellee, v.

WILLIAM MIKAITIS, Defendant‐Appellant. ____________________

Appeal from the United States District Court for the Northern District of Illinois, Eastern Division. No. 16 CR 361 — Virginia M. Kendall, Judge. ____________________

ARGUED NOVEMBER 10, 2021 — DECIDED APRIL 29, 2022 ____________________

Before MANION, ROVNER, and WOOD, Circuit Judges. MANION, Circuit Judge. William Mikaitis stood trial on drug charges. The government argued he was a no‐show doc‐ tor at a weight‐loss clinic who participated in illegally distrib‐ uting drugs. But he denied knowing about illegal activity. The district judge issued a deliberate‐avoidance instruction. The jury convicted. The judge sentenced Mikaitis to 30 months. He appeals, arguing that the evidence did not support the in‐ struction. But we affirm. 2 No. 20‐2783

I. Facts Michael Jennings ran Results Weight Loss Clinic in Lom‐ bard, Illinois. He was not a doctor or other medical profes‐ sional. He worked with a doctor to keep Results open, but that doctor lost his license. So Jennings needed another doctor. Someone connected Jennings to Mikaitis, a doctor licensed in Illinois with several decades of experience. They met around October 2012. Mikaitis was working full‐time for a hospital in Lockport, Illinois. Jennings offered to pay Mikaitis cash to se‐ cure a Drug Enforcement Agency registration number for the clinic and to review patient charts. Mikaitis agreed. So he ob‐ tained a DEA number and authorized Jennings to use it and Mikaitis’s credit card to order phentermine and other diet medications in bulk to distribute to patients. These diet pills are controlled substances. Over the next two years, Jennings ordered over 530,000 pills for over $84,000 using Mikaitis’s credit card and DEA number. Jennings reimbursed Mikaitis for these costs. The bulk drug shipments Jennings ordered were initially delivered to Mikaitis’s Lockport office. But Mikaitis allowed Jennings to take the drugs from Lockport to Results. And Mi‐ kaitis changed the delivery address so future shipments went directly to Results. Jennings saw many patients at Results. Mikaitis appeared weekly to get $1,750 cash and review four to eight charts. He always entered the clinic through a side door, went “right to Mr. Jennings’ office” to review the files set aside for him, and “didn’t look anywhere in the clinic,” according to Mikaitis’s testimony. He decided whether to allow drugs based on those charts. But Results also gave drugs—in person and by mail— to many patients whose charts he never reviewed. He testified No. 20‐2783 3

he knew Jennings lacked a medical license. Mikaitis testified he never saw any signs the clinic shipped out drugs. But a nurse practitioner who worked at the clinic testified she no‐ ticed almost immediately that Jennings was unlawfully dis‐ tributing drugs. She quit two days after starting. In all, Jennings paid Mikaitis about $98,000 cash, in addi‐ tion to reimbursement for over $85,000 in drug costs. Mikaitis deposited most of his weekly cash into a bank account he shared with his mistress, which funded their affair. II. Charges and Trial A grand jury indicted Mikaitis on 17 counts. Count 1 charged Mikaitis and Jennings with conspiracy “to knowingly and intentionally” distribute benzphenter‐ mine, phendimetrazine, and phentermine. Counts 2–8 charged them with “knowingly and intentionally” distrib‐ uting controlled substances “outside of the usual course of professional practice and without a legitimate medical pur‐ pose.” Counts 9–15 charged them with misbranding drugs, “with intent to defraud or mislead.” Count 16 charged them with conspiracy “to knowingly conduct and attempt to con‐ duct” a financial transaction involving proceeds from drug dealing. Count 17 charged Mikaitis with “knowingly en‐ gag[ing] and attempt[ing] to engage in” a monetary transac‐ tion involving criminally derived property. Mikaitis stood trial solo. A key dispute was his mens rea. The government had to prove his knowledge. He denied hav‐ ing guilty knowledge. During opening statements, defense counsel explained that as far as Mikaitis understood, the pa‐ tients would undergo exams to determine if they were fit for drugs, he would review the charts after these exams to 4 No. 20‐2783

determine if each patient qualified to receive drugs, and no patient would receive drugs without a legitimate medical purpose and his approval. The defense was that Jennings went behind Mikaitis’s back and committed crimes without his knowledge. The government marshaled a parade of nearly 20 wit‐ nesses to illegal activity at Results. Yet the theme of cross‐ex‐ aminations was: But you have no idea if Dr. Mikaitis knew of any of this alleged illegal activity, do you? For example, an Illinois health services investigator testified about the initial investigation of an anonymous complaint that Jennings acted as a doctor at Results without a license. The investigator de‐ termined Jennings was not a medical professional. But cross established that the complaint did not mention Mikaitis, that the investigator only saw Jennings give drugs to a patient out‐ side Mikaitis’s presence, and that the investigator did not hear if Jennings ever told Mikaitis about seeing that patient. De‐ fense pressed: “You have no way of knowing … whether Mi‐ chael Jennings lied to Dr. Mikaitis about what he was doing at that clinic when Dr. Mikaitis wasn’t there.” “That’s correct, sir.” As another example, a DEA agent testified she entered Re‐ sults posing as a new patient. Jennings weighed her and took her blood pressure but did not require other tests, conduct an exam, take blood, or discuss her medical history. Yet he sold her a bottle of phentermine. She did not see Mikaitis at Re‐ sults. But on cross, that was the main point: she never saw Mi‐ kaitis at Results. She did not hear if Jennings called Mikaitis and mentioned her. She did not know what Jennings told Mi‐ kaitis about who completed the forms or who took the blood‐ pressure information. She admitted she did not know if No. 20‐2783 5

Jennings ever reported her visit to Mikaitis or showed him her information. As yet another example, an actual patient testified that the first time she visited Results, she had her blood pressure and pulse checked and her history reviewed, and got a month’s worth of pills. Results did not do an exam, blood work, or any other tests. She returned a few times and found a similar pro‐ cess. After these initial visits, she stopped going in. Instead, she called and gave her blood pressure, weight, and payment. And Results mailed drugs to her. This happened monthly for about two years. She never returned to Results for any check‐ up. But again, cross suggested she could not implicate Mikai‐ tis. She did not recall ever seeing him at Results and did not know if he was shown her patient file or told about her visits. Nurse Practitioner Parminder Singh testified. She visited Results as a patient in February 2013. She only saw Jennings and assumed he was a medical provider. He weighed her and took her blood pressure but did no exam or other tests. Yet he gave her drugs. Learning her occupation, he asked her to cover Mikaitis. She agreed. She worked there for two days, in January 2014. She was the provider seeing patients. The only other person there was Jennings. She learned he was taking phone orders and arranging to mail drugs out. She asked about his medical background but he dodged. She realized after the second day he was not a medical provider. She left because staying jeopardized her license. Again, defense blamed Jennings and pursued its ignorance theme during cross. Singh reiterated that when she went to Results as a pa‐ tient and as an employee, the only other person present with Results was Jennings.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

SEC v. Kevin Duff
Seventh Circuit, 2025

Cite This Page — Counsel Stack

Bluebook (online)
33 F.4th 393, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-william-mikaitis-ca7-2022.